Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$148.58 USD
-0.69 (-0.46%)
Updated May 6, 2024 04:00 PM ET
After-Market: $148.74 +0.16 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Johnson & Johnson [JNJ]
Reports for Purchase
Showing records 41 - 60 ( 497 total )
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 7
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 70723
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 30.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 60123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 23.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 062123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 9.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 61123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 60123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 052123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended May 5.
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 51123
Provider: Stock Traders Daily
Analyst: Research Department